HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clerc, J. Articles by Fragu, P. Search for Related Content PubMed PubMed Citation Articles by Clerc, J. Articles by Fragu, P.

SIMS Microscopy Imaging of the Intratumor Biodistribution of Metaiodobenzylguanidine in the Human SK-N-SH Neuroblastoma Cell Line Xenografted into Nude Mice

Equipe de Microscopie Ionique - INSERM U 66, Institut Gustave-Roussy, Villejuif Cedex, France

Correspondence: For correspondence or reprints contact: Dr. Jéróme Clerc, INSERM U 66, Laboratoire de Microscopie Ionique Analytique, Institut Gustave Roussy, 39 rue Camille Desmoulina, 94805 Villejuif Cedex, France.

ABSTRACT

Microdosimetric evaluations of targeted radiotherapy of neuroblastoma with metaiodobenzylguanidine (MIBG) require precise assessment of the intracellular and intratumor distribution of the drug. We report the use of secondary ion mass spectrometry (SIMS) microscopy, a technique capable of mapping any chemical element within a biological specimen, to determine ¹²⁷I-MIBG bio distribution in human neuroblastoma SK-N-SH xenografted into nude mice. Highly specific images of ¹²⁷I-MIBG biodistribution were mapped within the tumor after in vivo administration of the drug and sample processing with cryotechniques (high-speed freezing and cryo-embedding), which prevent MIBG diffusion from original sites of uptake. We showed that the biodistribution of the tracer was highly nonuniform within the tumor. At the cellular level, most of the drug accumulated in the cytosol and perinuclear areas. In contrast, chemical sample processing provided not only a considerable loss in sensitivity due to passive diffusion of the drug in the organic solvents, but also artefactual images mainly due to MIBG redistribution onto the cell nuclei. Based on our findings in this SK-N-SH experimental tumor model, we suggest that MIBG should be attached to long-range emitters, in the hope of irradiating the many tumorous areas that remain carrier-free.

This article has been cited by other articles:

				F. Chehade, C. de Labriolle-Vaylet, N. Moins, M.-F. Moreau, J. Papon, P. Labarre, P. Galle, A. Veyre, and E. Hindie Secondary Ion Mass Spectrometry as a Tool for Investigating Radiopharmaceutical Distribution at the Cellular Level: The Example of I-BZA and 14C-I-BZA J. Nucl. Med., October 1, 2005; 46(10): 1701 - 1706. [Abstract] [Full Text] [PDF]

				Y. Naitoh, T. Sasajima, H. Kinouchi, S. Mikawa, and K. Mizoi Medulloblastoma with Extensive Nodularity: Single Photon Emission CT Study with Iodine-123 Metaiodobenzylguanidine AJNR Am. J. Neuroradiol., October 1, 2002; 23(9): 1564 - 1567. [Abstract] [Full Text] [PDF]

				S. MELLER Targeted radiotherapy for neuroblastoma Arch. Dis. Child., November 1, 1997; 77(5): 389 - 392. [Full Text]